PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines

J. Miller, M. Rahimi-Darabad, G. Travis (Hamilton, Canada)

Source: Annual Congress 2010 - State of the art imaging
Session: State of the art imaging
Session type: E-Communication Session
Number: 5288
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

Background: Regional health providers and policy makers (Cancer Care Ontario CCO and others) have determined PET/CT superior to conventional imaging (CI) in the solid organ staging (M) of operable non small cell lung cancer, (NSCLC) but have restricted access to PET/CT according to strict criteria. This prospective study was undertaken to determine if patients who do not meet CCO guidelines would similarly benefit from this preoperative investigation.
CCO published results of 337 patients average age 66 yrs half male . 23(14%) of 163 patients in PET/CT arm were correctly upstaged compared to 7% of the 157 patients who had CI (p=0.046). Therefore 7% of the patients avoided "inappropriate surgery".
Results: 54 patients with prsumed NSCLC at our centre, underwent PET/CT staging and not meet the CCO criteria and were selected on the bases of surgeon‘s discretion. 4 patients were excluded. 50 patients (24 male, 26 female) were included in the final analysis. PET-CT was supportive of all other investigations in 38 (76%); altered care by adding important new information in 7 (14%); and was misleading in 5 cases (8%).
Conclusion: This study mirors the CCO study. Preoperative staging with PET-CT for patients with lung cancer is a useful tool when applied based on surgeons discretion and can be as effective as when it is used based on the CCO guidelines.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Miller, M. Rahimi-Darabad, G. Travis (Hamilton, Canada). PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines. Eur Respir J 2010; 36: Suppl. 54, 5288

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does routine use of EBUS-TBNA and EUS-FNA improve the accuracy of staging of non small cell lung cancer patients – A national tumor registry based study
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011

High performance and timely care of integrated FDG-PET and diagnostic CT in a rapid outpatient diagnostic program for suspected lung cancer patients
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012


What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities
Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules
Year: 2018


Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC.
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020


Timely diagnosis and therapy for suspected lung cancer patients in a 2 day rapid outpatient diagnostic program with integrated FGD-PET and diagnostic CT
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012


Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021


Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Study to assess the utility of head CT in the staging of lung cancer in the post-PET era
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Use and limitations of TNM-based staging in lung cancer, assessed by current and new imaging procedures
Source: Annual Congress 2013 –PG2 Imaging in the management of thoracic malignancies
Year: 2013


Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Combining bronchoscopy and PET for assessment and staging of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 678s
Year: 2005

Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0.
Source: International Congress 2019 – General thoracic surgery
Year: 2019

Clinical strategy in patients with multiple synchronous suspect lung lesions. A reflection on the current TNM classification based on 54 cases with complete follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001

Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007


Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012